A highly multiplexed biochemical assay for analytes in dried blood spots: application to newborn screening and diagnosis of lysosomal storage disorders and other inborn errors of metabolism
被引:21
|
作者:
Hong, Xinying
论文数: 0引用数: 0
h-index: 0
机构:
Univ Washington, Dept Chem, Seattle, WA 98195 USAUniv Washington, Dept Chem, Seattle, WA 98195 USA
Hong, Xinying
[1
]
Sadilek, Martin
论文数: 0引用数: 0
h-index: 0
机构:
Univ Washington, Dept Chem, Seattle, WA 98195 USAUniv Washington, Dept Chem, Seattle, WA 98195 USA
Sadilek, Martin
[1
]
Gelb, Michael H.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Washington, Dept Chem, Seattle, WA 98195 USA
Univ Washington, Dept Biochem, Seattle, WA 98195 USAUniv Washington, Dept Chem, Seattle, WA 98195 USA
Gelb, Michael H.
[1
,2
]
机构:
[1] Univ Washington, Dept Chem, Seattle, WA 98195 USA
[2] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
Purpose To develop a multiplexed assay for the newborn screening of lysosomal storage disorders and additional inborn errors in a flexible, comprehensive, and affordable manner to keep up with the expansion of the newborn screening panel. Methods Ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was chosen as the detection platform for its superiority compared to traditional flow-injection MS/MS. Results A high-throughput, 18-plex UPLC-MS/MS assay was developed for screening purposes with a sample turnaround time of 2.7 minutes. The assay was consolidated such that only four dried blood spot punches were required, and it displayed good precision and reproducibility. Conclusion We report a highly multiplexed UPLC-MS/MS assay that is appropriate for the newborn screening of 15 lysosomal storage diseases and 3 additional inborn errors. It can be further expanded to include additional conditions for which presymptomatic diagnosis may facilitate optimum treatment outcome.